Filing step-change
VISTAPH · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-30 · Evidence medium
Vista Pharma Sees Upswing in Gross Margin Amidst Decline in Daily Volume and Marginal Operating Leverage.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 6.08 % | -2,584.21 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -2,584.21 % | -89.16 | ▼ |
Cite this
Source: Samhati filing step-change for VISTAPH (2026-09). Observation: Vista Pharma Sees Upswing in Gross Margin Amidst Decline in Daily Volume and Marginal Operating Leverage. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/vistaph/q/2026-09
Other periods